Kineta Inc. (KA)
NASDAQ: KA
· Real-Time Price · USD
0.57
-0.26 (-31.33%)
At close: Sep 18, 2024, 8:00 PM
-31.33% (1D)
| Bid | n/a |
| Market Cap | 7.05M |
| Revenue (ttm) | -4.34M |
| Net Income (ttm) | -20.88M |
| EPS (ttm) | -1.64 |
| PE Ratio (ttm) | -0.35036585365853656 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 480,683 |
| Avg. Volume (20D) | 504,100 |
| Open | 0.78 |
| Previous Close | 0.83 |
| Day's Range | 0.56 - 0.82 |
| 52-Week Range | 0.33 - 5.39 |
| Beta | 0.57 |
8 months ago
Kineta shares are trading higher after the company...
Unlock content with
Pro Subscription
10 months ago
Kineta shares are trading higher after the company announced that it entered into an exclusivity and right of first offer agreement with TuHURA Biosciences to grant the immune-oncology company exclusive rights to acquire its Anti-VISTA antibody.